LSE:GSK
LSE:GSKPharmaceuticals

GSK (LSE:GSK) Seeks European Expansion Of RSV Vaccine To Adults 18 And Older

Recently, GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV vaccine, Arexvy, to adults aged 18 and older. This announcement likely supported the company's 14% share price increase last month, alongside positive movements such as the FDA's review of linerixibat and early success in Tebipenem HBr trials. These advancements contrast the broader market, which experienced turbulence amid geopolitical tensions and surging oil...
AIM:RST
AIM:RSTCommercial Services

3 UK Stocks Estimated To Be Trading Below Fair Value By Up To 38.1%

The United Kingdom market has recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China, highlighting concerns about global economic recovery. In this environment, identifying stocks that are trading below their fair value can be an appealing strategy for investors looking to capitalize on potential long-term gains amidst broader market uncertainties.